JP2003527394A5 - - Google Patents

Download PDF

Info

Publication number
JP2003527394A5
JP2003527394A5 JP2001567739A JP2001567739A JP2003527394A5 JP 2003527394 A5 JP2003527394 A5 JP 2003527394A5 JP 2001567739 A JP2001567739 A JP 2001567739A JP 2001567739 A JP2001567739 A JP 2001567739A JP 2003527394 A5 JP2003527394 A5 JP 2003527394A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
mono
unsubstituted
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001567739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003527394A (ja
JP5000828B2 (ja
Filing date
Publication date
Priority claimed from EP00105514A external-priority patent/EP1134221A1/en
Priority claimed from EP00125169A external-priority patent/EP1209158A1/en
Application filed filed Critical
Priority claimed from PCT/EP2001/002237 external-priority patent/WO2001068648A1/en
Publication of JP2003527394A publication Critical patent/JP2003527394A/ja
Publication of JP2003527394A5 publication Critical patent/JP2003527394A5/ja
Application granted granted Critical
Publication of JP5000828B2 publication Critical patent/JP5000828B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001567739A 2000-03-15 2001-02-28 IkBキナーゼ阻害活性を有する置換ベーターカルボリン Expired - Fee Related JP5000828B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00105514A EP1134221A1 (en) 2000-03-15 2000-03-15 Substituted beta-carbolines as lkB kinase inhibitors
EP00105514.4 2000-03-15
EP00125169.3 2000-11-18
EP00125169A EP1209158A1 (en) 2000-11-18 2000-11-18 Substituted beta-carbolines
PCT/EP2001/002237 WO2001068648A1 (en) 2000-03-15 2001-02-28 Substituted beta-carbolines with ikb-kinase inhibiting activity

Publications (3)

Publication Number Publication Date
JP2003527394A JP2003527394A (ja) 2003-09-16
JP2003527394A5 true JP2003527394A5 (cg-RX-API-DMAC7.html) 2008-04-10
JP5000828B2 JP5000828B2 (ja) 2012-08-15

Family

ID=26070675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001567739A Expired - Fee Related JP5000828B2 (ja) 2000-03-15 2001-02-28 IkBキナーゼ阻害活性を有する置換ベーターカルボリン

Country Status (23)

Country Link
US (3) US6627637B2 (cg-RX-API-DMAC7.html)
JP (1) JP5000828B2 (cg-RX-API-DMAC7.html)
KR (1) KR100826817B1 (cg-RX-API-DMAC7.html)
CN (1) CN100509810C (cg-RX-API-DMAC7.html)
AT (1) ATE465161T1 (cg-RX-API-DMAC7.html)
AU (2) AU2001237418B2 (cg-RX-API-DMAC7.html)
BR (1) BR0109161A (cg-RX-API-DMAC7.html)
CA (1) CA2402549A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ301077B6 (cg-RX-API-DMAC7.html)
DE (1) DE60141895D1 (cg-RX-API-DMAC7.html)
EE (1) EE200200523A (cg-RX-API-DMAC7.html)
HK (1) HK1054039B (cg-RX-API-DMAC7.html)
HR (1) HRP20020748A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0300894A3 (cg-RX-API-DMAC7.html)
IL (2) IL151695A0 (cg-RX-API-DMAC7.html)
ME (1) MEP28108A (cg-RX-API-DMAC7.html)
MX (1) MXPA02007981A (cg-RX-API-DMAC7.html)
NO (1) NO324248B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ521386A (cg-RX-API-DMAC7.html)
PL (1) PL357284A1 (cg-RX-API-DMAC7.html)
RU (1) RU2277095C2 (cg-RX-API-DMAC7.html)
SK (1) SK13082002A3 (cg-RX-API-DMAC7.html)
YU (1) YU65502A (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402549A1 (en) * 2000-03-15 2001-09-20 Aventis Pharma Deutschland Gmbh Substituted beta-carbolines
CZ20032287A3 (cs) * 2001-02-01 2004-02-18 Bristol-Myers Squibb Company Způsoby léčení zánětlivých a imunitních nemocí za použití inhibitorů IkB kinázy (IKK)
DE60217532T8 (de) * 2001-11-07 2008-02-07 Millennium Pharmaceuticals, Inc., Cambridge Carboline derivate als ikb-inhibitoren zur behandlung des m ultiplen myelomas
US7462638B2 (en) * 2002-08-17 2008-12-09 Sanofi-Aventis Deutschland Gmbh Use of IκB-kinase inhibitors in pain therapy
US20040166095A1 (en) * 2003-02-25 2004-08-26 Blazar Bruce R. Methods for preventing GVHD
KR20060006031A (ko) * 2003-04-09 2006-01-18 밀레니엄 파머슈티컬스 인코퍼레이티드 염증 질환 치료에 유용한 베타-카르볼린
EP2206713A1 (en) * 2004-04-09 2010-07-14 Millennium Pharmaceuticals, Inc. Beta-carbolines useful for treating inflammatory disease
US8957070B2 (en) 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
EP1954290B1 (en) * 2005-11-22 2012-07-25 Merck Sharp & Dohme Corp. Tricyclic compounds useful as inhibitors of kinases
US20090131422A1 (en) * 2007-10-23 2009-05-21 Millennium Pharmaceuticals, Inc. Salts of an IKK inhibitor
WO2009054970A1 (en) * 2007-10-23 2009-04-30 Millennium Pharmaceuticals, Inc. Mesylate salt of an ikk inhibitor
AU2008343932B2 (en) 2007-12-19 2013-08-15 Amgen Inc. Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
CA2727055C (en) 2008-01-11 2016-12-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
CN101245066B (zh) * 2008-01-23 2010-11-10 复旦大学 一种制备7-烷氧基-2,9-二氮芴衍生物的方法
ATE531372T1 (de) * 2008-04-07 2011-11-15 Amgen Inc Gem-disubstituierte und spirocyclische aminopyridine/pyrimidine als zellcyclus- inhibitoren
US20110111417A1 (en) 2008-05-14 2011-05-12 Millennium Pharmaceuticals, Inc. Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
CA2726114A1 (en) * 2008-06-11 2009-12-17 Genentech, Inc. Diazacarbazoles and methods of use
PE20110365A1 (es) 2008-06-11 2011-07-11 Genentech Inc Diazacarbazoles como inhibidores de checkpoint quinasa 1 (chk1)
WO2010036567A2 (en) * 2008-09-25 2010-04-01 Osteogenex Inc. Harmine compounds for promoting bone growth
CN101717397B (zh) * 2008-10-09 2012-11-28 中国科学院上海药物研究所 一类取代吡啶并[2',1':2,3]咪唑并[4,5-c]异喹啉酮类化合物及其合成方法和用途,以及包含该类化合物的药物组合物
US8629158B2 (en) 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003005A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US20110183938A1 (en) * 2009-12-16 2011-07-28 Genentech, Inc. 1,7-diazacarbazoles and methods of use
RU2419431C1 (ru) * 2010-02-10 2011-05-27 Андрей Александрович Винник ПРОИЗВОДНЫЕ β-КАРБОЛИНА, ОБЛАДАЮЩИЕ ПРОТИВОТУБЕРКУЛЕЗНОЙ АКТИВНОСТЬЮ, ИХ ПРИМЕНЕНИЯ ДЛЯ ПРОИЗВОДСТВА ЛЕКАРСТВЕННОГО СРЕДСТВА, СПОСОБ ИХ СИНТЕЗА, А ТАКЖЕ НОВЫЕ МЕТОДЫ ЛЕЧЕНИЯ С ИХ ИСПОЛЬЗОВАНИЕМ
US8685969B2 (en) 2010-06-16 2014-04-01 Bristol-Myers Squibb Company Carboline carboxamide compounds useful as kinase inhibitors
US9168247B2 (en) 2010-06-25 2015-10-27 Facultes Universitaires Notre Dame De La Paix Beta carboline derivatives useful in the treatment of proliferative disorders
EP2455378A1 (en) * 2010-11-03 2012-05-23 Philip Morris Products S.A. Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
US8697700B2 (en) 2010-12-21 2014-04-15 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
JP5854492B2 (ja) * 2011-02-24 2016-02-09 国立大学法人 岡山大学 軟骨細胞分化誘導促進剤
KR101606250B1 (ko) 2011-03-23 2016-03-24 암젠 인크 Cdk 4/6 및 flt3의 융합된 트리사이클릭 이중 저해제
CN102250089B (zh) * 2011-05-20 2012-11-14 中国科学院南海海洋研究所 β-咔啉生物碱及其在制备抗疟疾药物中的应用
SI2968284T1 (sl) 2013-03-14 2021-08-31 Osteoqc Inc. Alkil-amin harmin derivati za pospeševanje rasti kosti
AP2015008858A0 (en) * 2013-05-28 2015-11-30 Astrazeneca Ab Chemical compounds
WO2015002926A1 (en) * 2013-07-02 2015-01-08 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
JP6434968B2 (ja) * 2013-07-02 2018-12-05 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Rock阻害剤としての三環式ピリド−カルボキサミド誘導体
EP4063358B1 (en) 2016-12-22 2024-05-22 Global Blood Therapeutics, Inc. Histone methyltransferase inhibitors
MX2019014759A (es) * 2017-06-09 2020-02-12 Global Blood Therapeutics Inc Compuestos de azaindol como inhibidores de metiltransferasa de histona.
CA3090241C (en) * 2018-04-25 2023-03-28 Oncocross Co.,Ltd. Composition for preventing and treating muscular disease
EP3836923B1 (en) 2018-08-14 2024-10-16 OssiFi Therapeutics LLC Pyrrolo - dipyridine compounds for the treatment of bone loss
JP7695496B2 (ja) 2018-08-14 2025-06-19 オシフィ セラピューティクス リミティド ライアビリティ カンパニー フルオロβ-カルボリン化合物
WO2020072675A1 (en) 2018-10-02 2020-04-09 Northwestern University Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c)
CN111374975A (zh) * 2018-12-27 2020-07-07 北京大学 去氢骆驼蓬碱的药物用途
CN112047940B (zh) * 2020-08-28 2021-06-29 南通大学 含1-(3,4-二甲氧基苯基)-β-咔啉单元的吡唑化合物的制备与用途
US20250388584A1 (en) * 2022-07-14 2025-12-25 Shanghai Raising Pharmaceutical Co., Ltd. Tpk agonist and method for treating neurodegenerative diseases using same
US11939330B1 (en) * 2023-08-25 2024-03-26 King Faisal University Pyrido[3,4-b]indole-6-carboxylic acid compounds as CK2 inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE568675C (de) * 1930-10-04 1933-01-27 Boots Pure Drug Co Ltd Verfahren zur Herstellung von O-Alkyl-, Oxyalkyl- oder Alkylaminoalkylaethern des Harmols oder Harmalols
DK72180A (da) * 1979-04-10 1980-10-11 Ciba Geigy Ag Fremgangsmaade til fremstilling af diazatricycler samt salte deraf
DE3240514A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4631149A (en) 1983-07-25 1986-12-23 University Of Illinois Antiviral eudistomins from a marine tunicate
JPS63250378A (ja) * 1987-04-07 1988-10-18 Mitsubishi Kasei Corp インド−ル誘導体
CA2140722A1 (en) 1994-01-24 1995-07-25 Joseph A. Jakubowski Beta-carboline thromboxane synthase inhibitors
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US5532261A (en) * 1994-12-12 1996-07-02 Merck & Co., Inc. Carbapenem antibiotics, compositions containing such compounds and methods of use
JP2000516231A (ja) * 1996-08-09 2000-12-05 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 免疫調節物質としての4―置換β―カルボリン
EP0827746B1 (en) * 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
US5843721A (en) 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
ZA9810766B (en) * 1997-11-28 1999-05-25 Mochida Pharm Co Ltd Novel compounds having cgmp-pde inhibitory activity
DE19807993A1 (de) * 1998-02-26 1999-09-02 Bayer Ag Verwendung von ß-Carbolinderivaten zur Bekämpfung von TNF-alpha-abhängigen Krankheiten
CA2402549A1 (en) * 2000-03-15 2001-09-20 Aventis Pharma Deutschland Gmbh Substituted beta-carbolines

Similar Documents

Publication Publication Date Title
KR100826817B1 (ko) 치환된 베타-카볼린
US10220030B2 (en) Amino-quinolines as kinase inhibitors
US10836770B2 (en) Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses
CN102918034B (zh) 多取代芳族化合物作为凝血酶的抑制剂
TWI567073B (zh) 用於治療發炎疾病之新穎二氫嘧啶異喹啉酮及醫藥組成物
JP2021507897A (ja) Lpaアンタゴニストとしてのピラゾールo−架橋カルバモイルシクロヘキシル酸
EP3143021A1 (en) Pyrazolopyridines and pyrazolopyrimidines
US9409917B2 (en) Heterocyclic amide derivatives as P2X7 receptor antagonists
WO1995028387A1 (en) Benzamide compound and medicinal use thereof
JP2016517895A (ja) 嚢胞性線維症を処置するための新規化合物およびこれらの医薬組成物
CN106188045A (zh) 作为wnt信号传导抑制剂的化合物、组合物及其应用
TW201841911A (zh) 4-吡啶酮化合物或其鹽、包含4-吡啶酮化合物之藥物組成物及劑
EP1209158A1 (en) Substituted beta-carbolines
JP2005506330A (ja) ケモカイン(特にccr3)活性のモジュレーターとしてのピペリジン誘導体およびその使用
JPH0225913B2 (cg-RX-API-DMAC7.html)
CA3140017A1 (en) Polyaromatic urea derivatives and their use in the treatment of muscle diseases
EP1530468A1 (de) Substituierte isoxazolderivate und ihre verwendung in der pharmazie
WO2017073743A1 (ja) 三環性化合物
JP2002529463A (ja) 化合物
JP5704924B2 (ja) 新規複素環化合物
US20050020587A1 (en) Nicotinamide derivatives useful as PDE4 inhibitors
ES2250750T3 (es) Aroil piridinonas.
JP2006528659A (ja) Pde4阻害剤として有用なニコチンアミド誘導体
JPH0273084A (ja) 心臓血管系に作用する化合物
CN121591722A (zh) 作为蛋白质酪氨酸磷酸酶抑制剂的含双键取代的化合物及其应用